Due to low bioavailability
of dietary phenolic compounds in small
intestine, their metabolism by gut microbiota is gaining increasing
attention. The microbial metabolism of theasinensin A (TSA), a bioactive
catechin dimer found in black tea, has not been studied yet. Here,
TSA was extracted and purified for
in vitro
fermentation
by human fecal microbiota, and epigallocatechin gallate (EGCG) and
procyanidin B2 (PCB2) were used for comparison. Despite the similarity
in their flavan-3-ol skeletons, metabolic fate of TSA was distinctively
different. After degalloylation, its core biphenyl-2,2′,3,3′,4,4′-hexaol
structure remained intact during fermentation. Conversely, EGCG and
PCB2 were promptly degraded into a series of hydroxylated phenylcarboxylic
acids. Computational analyses comparing TSA and PCB2 revealed that
TSA’s stronger interflavanic bond and more compact stereo-configuration
might underlie its lower fermentability. These insights in the recalcitrance
of theasinensins to degradation by human gut microbiota are of key
importance for a comprehensive understanding of its health benefits.